Cargando…
Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa
Treatment of tuberculosis (TB) and HIV co-infections is often complicated by drug-to-drug interactions between anti-mycobacterial and anti-retroviral agents. Rifabutin (RFB) is an alternative to rifampin (RIF) for TB regimens and is recommended for HIV patients concurrently receiving protease inhibi...
Autores principales: | Rukasha, Ivy, Said, Halima M., Omar, Shaheed V., Koornhof, Hendrik, Dreyer, Andries W., Musekiwa, Alfred, Moultrie, Harry, Hoosen, Anwar A., Kaplan, Gilla, Fallows, Dorothy, Ismail, Nazir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136537/ https://www.ncbi.nlm.nih.gov/pubmed/27994580 http://dx.doi.org/10.3389/fmicb.2016.01947 |
Ejemplares similares
-
rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis
por: Li, Ma-Chao, et al.
Publicado: (2022) -
A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings
por: Said, Halima M., et al.
Publicado: (2016) -
rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
por: Li, Ma-chao, et al.
Publicado: (2021) -
Differential Impact of the rpoB Mutant on Rifampin and Rifabutin Resistance Signatures of Mycobacterium tuberculosis Is Revealed Using a Whole-Genome Sequencing Assay
por: Yu, Ming-Chih, et al.
Publicado: (2022) -
Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
por: Jing, Wei, et al.
Publicado: (2017)